The added value of quantitative multi-voxel MR spectroscopy in breast magnetic resonance imaging

European Radiology

Volumn 22, Issue 4, 2012, Pages 915-922

  Dorrius, M D ^a   Pijnappel, R M ^a   Van Der Weide Jansen, M C ^a   Jansen, L ^a   Kappert, P ^a   Oudkerk, M ^a   Sijens, P E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Breast; Chemical shift imaging; Choline; Magnetic resonance imaging; Spectroscopy

Indexed keywords

CHOLINE; WATER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST DISEASE; BREAST LESION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VOXEL BASED MORPHOMETRY;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84861459366     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2322-0     Document Type: Article

References (46)

1. Bluemke DA, Gatsonis CA, Chen MH, DeAngelis GA, DeBruhl N, Harms S, Heywang-Kobrunner SH, Hylton N, Kuhl CK, Lehman C, Pisano ED, Causer P, Schnitt SJ, Smazal SF, Stelling CB, Weatherall PT, Schnall MD (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292:2735-2742
2. Hrung JM, Sonnad SS, Schwartz JS, Langlotz CP (1999) Accuracy of MR imaging in the work-up of suspicious breast lesions: a diagnostic meta-analysis. Acad Radiol 6:387-397
3. Peters NH, Borel Rinkes IH, Zuithoff NP, Mali WP, Moons KG, Peeters PH (2008) Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology 246:116-124
4. Kuhl CK, Schmutzler RK, Leutner CC, Kempe A, Wardelmann E, Hocke A, Maringa M, Pfeifer U, Krebs D, Schild HH (2000) Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215:267-279
5. Moy L, Elias K, Patel V, Lee J, Babb JS, Toth HK, Mercado CL (2009) Is breast MRI helpful in the evaluation of inconclusive mammographic findings? AJR Am J Roentgenol 193:986-993
6. Vassiou K, Kanavou T, Vlychou M, Poultsidi A, Athanasiou E, Arvanitis DL, Fezoulidis IV (2009) Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Eur J Radiol 70:69-76
7. American College of Radiology (ACR): Illustrated breast imaging reporting and data system (BI-RADS), 1998. http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/BIRADSAtlas/BIRADSAtlasexcerptedtext. aspx
8. Ikeda DM, Baker DR, Daniel BL (2000) Magnetic resonance imaging of breast cancer: clinical indications and breast MRI reporting system. J Magn Reson Imaging 12:975-983
9. Ikeda DM, Hylton NM, Kinkel K, Hochman MG, Kuhl CK, Kaiser WA, Weinreb JC, Smazal SF, Degani H, Viehweg P, Barclay J, Schnall MD (2001) Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 13:889-895
10. Ikeda DM (2001) Progress report from the American College of Radiology Breast MR Imaging Lexicon Committee. Magn Reson Imaging Clin N Am 9:295-302
11. Agency for Health Care Research and Quality Effectiveness of non-invasive diagnostic test for breast abnormalities. AHRQ publication no. 06-EHC005-EF, 2006, 2009. http://www.ahrq.gov/
12. Tardivon AA, Athanasiou A, Thibault F, El KC (2007) Breast imaging and reporting data system (BIRADS): magnetic resonance imaging. Eur J Radiol 61:212-215
13. Bartella L, Morris EA, Dershaw DD, Liberman L, Thakur SB, Moskowitz C, Guido J, Huang W (2006) Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 239:686-692
14. Bartella L, Thakur SB, Morris EA, Dershaw DD, Huang W, Chough E, Cruz MC, Liberman L (2007) Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology 245:80-87
15. Baek HM, Chen JH, Nalcioglu O, Su MY (2008) Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Ann Oncol 19:1022-1024
16. Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O (2006) Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA 19:96-104
17. Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, Everson LI, Yee D, Garwood M (2003) In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50:1134-1143
18. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE (2001) The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68:45-54
19. Gribbestad IS, Singstad TE, Nilsen G, Fjosne HE, Engan T, Haugen OA, Rinck PA (1998) In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 8:1191-1197
20. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM (2004) Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232:585-591
21. Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK (2001) Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 84:1016-1022
22. Joe BN, Chen VY, Salibi N, Fuangtharntip P, Hildebolt CF, Bae KT (2005) Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol 40:405-411
23. Kvistad KA, Bakken IJ, Gribbestad IS, Ehrnholm B, Lundgren S, Fjosne HE, Haraldseth O (1999) Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 10:159-164
24. Lee J, Yamaguchi T, Abe A, Shizukuishi K, Uemura H, Miyagi E, Sakata K, Inoue T (2004) Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors. Radiat Med 22:148-154
25. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE (1998) Human breast lesions: characterization with proton MR spectroscopy. Radiology 209:269-275
26. Stanwell P, Gluch L, Clark D, Tomanek B, Baker L, Giuffre B, Lean C, Malycha P, Mountford C (2005) Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T. Eur Radiol 15:1037-1043
27. Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy initial results. Radiology 220:40-46
28. Baek HM, Chen JH, Nie K, Yu HJ, Bahri S, Mehta RS, Nalcioglu O, Su MY (2009) Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 251:653-662
29. Sardanelli F, Fausto A, Di Leo G, de Nijs R, Vorbuchner M, Podo F (2009) In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy. AJR Am J Roentgenol 192:1608-1617
30. Tozaki M, Fukuma E (2009) 1H MR spectroscopy and diffusionweighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy? AJR Am J Roentgenol 193:840-849
31. TseGM, Cheung HS, PangLM, ChuWC, LawBK, Kung FY,Yeung DK (2003) Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 181:1267-1272
32. Yeung DK, Yang WT, Tse GM (2002) Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 225:190-197
33. Bakken IJ, Gribbestad IS, Singstad TE, Kvistad KA (2001) External standard method for the in vivo quantification of cholinecontaining compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 46:189-192
34. Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY (2008) Detection of choline signal in human breast lesions with chemical-shift imaging. J Magn Reson Imaging 27:1114-1121
35. Geraghty PR, van den Bosch MA, Spielman DM, Hunjan S, Birdwell RL, Fong KJ, Stables LA, Zakhour M, Herfkens RJ, Ikeda DM (2008) MRI and (1)H MRS of the breast: presence of a choline peak as malignancy marker is related to K21 value of the tumor in patients with invasive ductal carcinoma. Breast J 14:574-580
36. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68-75
37. Jacobs MA, Barker PB, Argani P, Ouwerkerk R, Bhujwalla ZM, Bluemke DA (2005) Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 21:23-28
38. Sijens PE, Dorrius MD, Kappert P, Baron P, Pijnappel RM, Oudkerk M (2010) Quantitative multivoxel proton chemical shift imaging of the breast. Magn Reson Imaging 28:314-319
39. Stanwell P, Mountford C (2007) In vivo proton MR spectroscopy of the breast. Radiographics 27:S253-S266
40. Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O (2006) Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat 5:401-410
41. Sijens PE, van den Bent MJ, Nowak PJ, van Dijk P, Oudkerk M (1997) 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 37:222-225
42. Sijens PE, Oudkerk M, van Dijk P, Levendag PC, Vecht CJ (1998) 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imaging 16:1273-1280
43. Eby PR, Demartini WB, Peacock S, Rosen EL, Lauro B, Lehman CD (2007) Cancer yield of probably benign breast MR examinations. J Magn Reson Imaging 26:950-955
44. Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus- Linthorst MM, Muller SH, Meijer S, Oosterwijk JC, Beex LV, Tollenaar RA, de Koning HJ, Rutgers EJ, Klijn JG (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437
45. Liberman L, Morris EA, Benton CL, Abramson AF, Dershaw DD (2003) Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women. Cancer 98:377-388
46. Sadowski EA, Kelcz F (2005) Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination. J Magn Reson Imaging 21:556-564